Grauer & Weil (india) Share Price
Sector: Chemical Manufacturing
86.44 -3.61 (-4.01%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
84.95
Today’s High
90.92
52 Week Low
72.16
52 Week High
120.00
Key Metrics
- Market Cap (In Cr) 3919.29
- Beta 0.91
- Div. Yield (%) 0.56
- P/B 5.07
- TTM P/E 29.27
- Peg Ratio 0.89
- Sector P/E 17.73
- Open Price 90.2
- Prev Close 90.05
Grauer & Weil (india) Analysis
Price Analysis
-
1 Week6.81%
-
3 Months-10.31%
-
6 Month-20.38%
-
YTD-13.16%
-
1 Year-5.16%
Risk Meter
- 36% Low risk
- 36% Moderate risk
- 36% Balanced Risk
- 36% High risk
- 36% Extreme risk
Grauer & Weil (india) Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 1068.9
- Selling/ General/ Admin Expenses Total
- 178.34
- Depreciation/ Amortization
- 21.12
- Other Operating Expenses Total
- 3.01
- Total Operating Expense
- 899.52
- Operating Income
- 169.37
- Net Income Before Taxes
- 196.22
- Net Income
- 146.28
- Diluted Normalized EPS
- 3.22
- Period
- 2024
- Total Assets
- 1125.29
- Total Liabilities
- 320.1
- Total Equity
- 805.2
- Tangible Book Valueper Share Common Eq
- 17.63
- Period
- 2024
- Cashfrom Operating Activities
- 159.08
- Cashfrom Investing Activities
- -108.15
- Cashfrom Financing Activities
- -20.24
- Net Changein Cash
- 30.69
- Period
- 2023
- Total Revenue
- 981.82
- Selling/ General/ Admin Expenses Total
- 151.82
- Depreciation/ Amortization
- 19.81
- Other Operating Expenses Total
- 1.84
- Total Operating Expense
- 846.99
- Operating Income
- 134.84
- Net Income Before Taxes
- 151.96
- Net Income
- 112.95
- Diluted Normalized EPS
- 2.5
- Period
- 2023
- Total Assets
- 954.27
- Total Liabilities
- 275.05
- Total Equity
- 679.22
- Tangible Book Valueper Share Common Eq
- 14.86
- Period
- 2023
- Cashfrom Operating Activities
- 113.5
- Cashfrom Investing Activities
- -111.07
- Cashfrom Financing Activities
- -23.53
- Net Changein Cash
- -21.1
- Period
- 2022
- Total Revenue
- 768.29
- Selling/ General/ Admin Expenses Total
- 127.68
- Depreciation/ Amortization
- 19.63
- Other Operating Expenses Total
- 2.34
- Total Operating Expense
- 672.59
- Operating Income
- 95.7
- Net Income Before Taxes
- 106.82
- Net Income
- 78.77
- Diluted Normalized EPS
- 1.7
- Period
- 2022
- Total Assets
- 823.99
- Total Liabilities
- 241.58
- Total Equity
- 582.42
- Tangible Book Valueper Share Common Eq
- 12.83
- Period
- 2022
- Cashfrom Operating Activities
- 43.89
- Cashfrom Investing Activities
- -16.56
- Cashfrom Financing Activities
- -15.03
- Net Changein Cash
- 12.3
- Period
- 2021
- Total Revenue
- 605.83
- Selling/ General/ Admin Expenses Total
- 101.32
- Depreciation/ Amortization
- 18.41
- Other Operating Expenses Total
- 1.55
- Total Operating Expense
- 523.41
- Operating Income
- 82.42
- Net Income Before Taxes
- 94.24
- Net Income
- 68.81
- Diluted Normalized EPS
- 1.47
- Period
- 2021
- Total Assets
- 749.86
- Total Liabilities
- 235.83
- Total Equity
- 514.03
- Tangible Book Valueper Share Common Eq
- 11.32
- Period
- 2021
- Cashfrom Operating Activities
- 116.73
- Cashfrom Investing Activities
- -42.73
- Cashfrom Financing Activities
- -2.66
- Net Changein Cash
- 71.34
- Period
- 2020
- Total Revenue
- 619.4
- Selling/ General/ Admin Expenses Total
- 125.09
- Depreciation/ Amortization
- 19.01
- Other Operating Expenses Total
- 1.76
- Total Operating Expense
- 533.18
- Operating Income
- 86.23
- Net Income Before Taxes
- 95.41
- Net Income
- 75.84
- Diluted Normalized EPS
- 1.52
- Period
- 2020
- Total Assets
- 641.94
- Total Liabilities
- 197.14
- Total Equity
- 444.81
- Tangible Book Valueper Share Common Eq
- 9.79
- Period
- 2020
- Cashfrom Operating Activities
- 84.04
- Cashfrom Investing Activities
- -52.78
- Cashfrom Financing Activities
- -36.5
- Net Changein Cash
- -5.23
- Period
- 2019
- Total Revenue
- 601.08
- Selling/ General/ Admin Expenses Total
- 118.07
- Depreciation/ Amortization
- 15.49
- Other Operating Expenses Total
- 4.91
- Total Operating Expense
- 517.7
- Operating Income
- 83.38
- Net Income Before Taxes
- 94.12
- Net Income
- 63.87
- Diluted Normalized EPS
- 1.5
- Period
- 2019
- Total Assets
- 581.2
- Total Liabilities
- 179.96
- Total Equity
- 401.25
- Tangible Book Valueper Share Common Eq
- 8.82
- Period
- 2019
- Cashfrom Operating Activities
- 32.51
- Cashfrom Investing Activities
- -13.14
- Cashfrom Financing Activities
- -2.25
- Net Changein Cash
- 17.12
- Period
- 2024-12-31
- Total Revenue
- 274.8
- Selling/ General/ Admin Expenses Total
- 28.15
- Depreciation/ Amortization
- 5.71
- Other Operating Expenses Total
- 58.67
- Total Operating Expense
- 228.2
- Operating Income
- 46.6
- Net Income Before Taxes
- 57.97
- Net Income
- 43.12
- Diluted Normalized EPS
- 0.95
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 254.69
- Selling/ General/ Admin Expenses Total
- 27.97
- Depreciation/ Amortization
- 5.52
- Other Operating Expenses Total
- 53.83
- Total Operating Expense
- 217.52
- Operating Income
- 37.17
- Net Income Before Taxes
- 50.59
- Net Income
- 37.61
- Diluted Normalized EPS
- 0.83
- Period
- 2024-09-30
- Total Assets
- 1204.23
- Total Liabilities
- 334.57
- Total Equity
- 869.66
- Tangible Book Valueper Share Common Eq
- 19.05
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 51.48
- Cashfrom Investing Activities
- -24.14
- Cashfrom Financing Activities
- -17.66
- Net Changein Cash
- 9.68
- Period
- 2024-06-30
- Total Revenue
- 264.09
- Selling/ General/ Admin Expenses Total
- 28.77
- Depreciation/ Amortization
- 5.35
- Other Operating Expenses Total
- 56.71
- Total Operating Expense
- 205.59
- Operating Income
- 58.5
- Net Income Before Taxes
- 66.68
- Net Income
- 50.71
- Diluted Normalized EPS
- 1.12
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 333.12
- Selling/ General/ Admin Expenses Total
- 28.25
- Depreciation/ Amortization
- 5.38
- Other Operating Expenses Total
- 66.86
- Total Operating Expense
- 299.22
- Operating Income
- 33.9
- Net Income Before Taxes
- 39.2
- Net Income
- 29.17
- Diluted Normalized EPS
- 0.64
- Period
- 2024-03-31
- Total Assets
- 1125.29
- Total Liabilities
- 320.1
- Total Equity
- 805.2
- Tangible Book Valueper Share Common Eq
- 17.63
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 159.08
- Cashfrom Investing Activities
- -108.15
- Cashfrom Financing Activities
- -20.24
- Net Changein Cash
- 30.69
- Period
- 2023-12-31
- Total Revenue
- 285.03
- Selling/ General/ Admin Expenses Total
- 28.47
- Depreciation/ Amortization
- 5.36
- Other Operating Expenses Total
- 53.61
- Total Operating Expense
- 235.82
- Operating Income
- 49.21
- Net Income Before Taxes
- 58.16
- Net Income
- 42.75
- Diluted Normalized EPS
- 0.95
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Grauer & Weil (india) Technical
Moving Average
SMA
- 5 Day88.07
- 10 Day85.93
- 20 Day86.27
- 50 Day88.96
- 100 Day95.35
- 300 Day97.55
Grauer & Weil (india) Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Bharat Rasayan
- 9811
- -6.4
- -0.07
- 14281.35
- 9021
- 4177.08
- Neogen Chemicals
- 1558
- -42.85
- -2.68
- 2414.9
- 1340
- 4108.21
- Grauer & Weil (india)
- 86.44
- -3.61
- -4.01
- 120
- 72.16
- 3919.29
- Nacl Industries
- 179.8
- -9.45
- -4.99
- 220.1
- 48.6
- 3585.92
- Rossari Biotech
- 693.7
- -10.9
- -1.55
- 966
- 568.05
- 3838.13
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Bharat Rasayan
- 43.47
- 4.2
- 19.64
- 12.19
- Neogen Chemicals
- 115.08
- 5.57
- 11.35
- 7.59
- Grauer & Weil (india)
- 28.51
- 5.18
- 17.09
- 11.93
- Nacl Industries
- -
- 7.74
- 7.92
- 2.29
- Rossari Biotech
- 30.09
- 3.71
- 16.03
- 7.66
Grauer & Weil (india) Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 06-Feb-25
- Quarterly Results
- 24-Oct-24
- Quarterly Results
- 12-Aug-24
- Quarterly Results & A.G.M.
- 28-May-24
- Audited Results, Final Dividend & A.G.M.
- 26-Feb-24
- Bonus issue
- 09-Feb-24
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results
- 27-May-23
- Audited Results, Final Dividend & A.G.M.
- 23-May-23
- Audited Results, F. Dividend & A.G.M.
- Meeting Date
- Announced on
- Purpose
- 25-Sept-24
- 14-Aug-24
- AGM
- 02-Apr-24
- 28-Feb-24
- POM
- 10-Aug-23
- 29-May-23
- AGM
- 29-Sept-21
- 30-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 28-May-24
- -
- 20-Sept-24
- 0.5
- 29-May-23
- -
- 04-Aug-23
- 0.8
- 30-Jun-21
- -
- 20-Sept-21
- 0.5
- Announced on
- Record Date
- Ex-Bonus
- Description
- 26-Feb-24
- 10-Apr-24
- 10-Apr-24
- Bonus issue of equity shares in the ratio of 1:1 of Re. 1/-.

